Making Sense of Cancer Screening Updates
TUESDAY, Dec. 20 (HealthDay News) -- As experts alter course on
guidelines for cancer screenings such as mammograms and the
prostate-specific antigen test, the general public is
understandably confused.
Buildup of Newer Flame Retardants Concerns Scientists
TUESDAY, Dec. 20 (HealthDay News) -- Increasing concentrations
of two newer generation flame-retardant chemicals were detected in
atmospheric samples collected in the Great Lakes region between
2008 and 2010, a new study indicates.
Youth Exposure to Unwanted Internet Sexual Encounters Drops
TUESDAY, Dec. 20 (HealthDay News) -- Increased public awareness
and improved Internet security may be among the reasons why child
and teen exposure to unwanted online sexual solicitations and
pornography has declined in the United States, a new study
indicates.
Endometriosis Tied to Higher Risk of Crohn's, Colitis
MONDAY, Dec. 19 (HealthDay News) -- Women with endometriosis may
be up to 80 percent more likely to develop inflammatory bowel
disease such as Crohn's disease or ulcerative colitis compared to
women without the uterine disorder, according to a new long-term
study.
Mindfulness Training May Help Arthritis Patients Cope
TUESDAY, Dec. 20 (HealthDay News) -- A small study finds that
mindfulness training, which teaches people to push away troublesome
thoughts, helped improve well-being in people with rheumatoid
arthritis and similar diseases.
Driving Isn't An Issue for Most People With Diabetes
TUESDAY, Dec. 20 (HealthDay News) -- Diabetes needn't prevent
someone from driving, and only a doctor should decide if
complications are severe enough to keep an individual off the road,
the American Diabetes Association (ADA) says.
Edarbyclor Approved for High Blood Pressure
TUESDAY, Dec. 20 (HealthDay News) -- Edarbyclor (azilsartan
medoxomil and chlorthalidone) has been approved by the U.S. Food
and Drug Administration to treat high blood pressure in adults,
maker Takeda Pharmaceutical Co. Ltd. said Tuesday in a news
release.